Skip to content

Preferred Stock at other companies

Revolution Medicines, Inc. logo
Revolution Medicines, Inc.RVMD
$0
Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
$0
Revvity logo
RevvityRVTY
$0
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$0
ALN
Alnylam PharmaceuticalsALNY
$0
Rhythm Pharmaceuticals, Inc. logo
Rhythm Pharmaceuticals, Inc.RYTM
$0

Other financials

Income statement

See full
Revenue$3.0M-60.9%
Operating income-$78.6M+7.4%
Net income-$73.3M+4.9%
EPS (diluted)-$0.41+10.9%

Balance sheet

See full
Cash & equivalents$204.6M+119%
Total debt$31.6M-33.1%
Total equity$642.2M-10.9%
Total assets$699.6M-12.5%

Cash flow

See full
Operating cash flow-$51.1M+30.2%
CapEx$1.0K
Free cash flow-$44.9M+22.5%

Valuation

See full
Market cap$3.8B+300%

Profitability

See full
Operating margin-2,776.6%-820pp
Net margin-2,554.1%-745pp
FCF margin-1,536%-429pp

Returns & leverage

See full
Return on equity-40%-4.3pp
Debt / equity0.0×
Current ratio22.1×+2.2×

Where this comes from

Reported directly by Relay Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PreferredStockValue.

The official record: Relay Therapeutics, Inc.’s 10-K, filed February 24, 2022, on SEC EDGAR. View the filing →

Questions, answered.

What is Relay Therapeutics, Inc.'s preferred stock?
Relay Therapeutics, Inc. (RLAY) reported preferred stock of $0 in Q4 2021.
What does preferred stock mean?
Equity securities with priority over common stock for dividends and liquidation proceeds, but typically without voting rights.